Medical Articles 5/29

Posted by rob on May 29, 2009 under Uncategorized | Be the First to Comment

Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia.

Treatment selection after imatinib resistance in chronic myeloid leukemia.

The metabolic consequences of imatinib mesylate: Changes on glucose, lypidic and bone metabolism.

GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.

Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.

Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations.

A myeloproliferative disorder may hide another one.

Vitiligo-like lesions in an adult patient treated with Imatinib mesylate.

Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia.

Add A Comment

You must be logged in to post a comment.

home top